National Cancer Institute; Amended Notice of Meeting, 12111 [2016-05018]

Download as PDF 12111 Federal Register / Vol. 81, No. 45 / Tuesday, March 8, 2016 / Notices Dated: March 2, 2016. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–05020 Filed 3–7–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Proposed Collection; 60-Day Comment Request; Survey To Assess the Feasibility of Establishing a Gynecologic Specimen Bank (NCI) In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Cancer Institute, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. Written comments and/or suggestions from the public and affected agencies are invited to address one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have SUMMARY: practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) The quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. gynecologic specimen bank (NCI), 0925– NEW, National Cancer Institute (NCI), National Institutes of Health (NIH). Need and Use of Information Collection: The National Cancer Institute is assessing the feasibility of developing a tissue bank that would include tube and ovary tissues from women undergoing surgery for benign conditions, risk reduction and early stage cancer. Collecting tissues from tubes and ovaries containing clinically unsuspected precursors or early stage cancer is challenging, especially among women that are not at increased genetic risk. However, given that many pathology laboratories have enhanced their processing protocols for gynecologic surgical specimens removed for benign indications, it may be possible to develop a tissue resource. Accordingly, we are requesting information via a survey about the volume of samples that are accessioned at different pathology laboratories, and the methods used to process these samples. These data would provide information necessary to assess the feasibility of establishing a tissue bank for research and provide insights into the best design of a pilot study. OMB approval is requested for 1 year. There are no costs to respondents other than their time. The total estimated annualized burden hours are 42 hours. TO SUBMIT COMMENTS AND FOR FURTHER INFORMATION: To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Goli Samimi, Program Director, Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, 9609 Medical Center Drive, MSC 9783, Bethesda, MD 20892, or call non-toll-free number (240) 276–6582, or Email your request, including your address to: goli.samimi@nih.gov. Formal requests for additional plans and instruments must be requested in writing. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: Survey to assess the feasibility of establishing a ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Frequency of response per respondent Time per response (in hours) Category of respondent Form name Lab Managers ....................................................... Survey. .......................... 250 1 10/60 42 Totals ............................................................. ....................................... 250 ........................ ........................ 42 Dated: March 2, 2016. Karla Bailey, Project Clearance Liaison, National Cancer Institute, NIH. Health, 31 Center Drive, Building 31, Conference Room 10, Bethesda, MD, 20892 which was published in the Federal Register on February 26, 2016, 81 FR 9867. The meeting notice is amended to change the meeting date to March 29, 2016. The meeting is open to the public. [FR Doc. 2016–05021 Filed 3–7–16; 8:45 am] BILLING CODE 4140–01–P asabaliauskas on DSK3SPTVN1PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: March 2, 2016. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. National Institutes of Health National Cancer Institute; Amended Notice of Meeting [FR Doc. 2016–05018 Filed 3–7–16; 8:45 am] BILLING CODE 4140–01–P Notice is hereby given of a change in the meeting of the National Cancer Institute Board of Scientific Advisors, March 29, 2016, 08:30 a.m. to March 30, 2016, 12:00 p.m., National Institutes of VerDate Sep<11>2014 17:02 Mar 07, 2016 Jkt 238001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 Burden hours DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, E:\FR\FM\08MRN1.SGM 08MRN1

Agencies

[Federal Register Volume 81, Number 45 (Tuesday, March 8, 2016)]
[Notices]
[Page 12111]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-05018]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Cancer Institute Board of Scientific Advisors, March 29, 2016, 08:30 
a.m. to March 30, 2016, 12:00 p.m., National Institutes of Health, 31 
Center Drive, Building 31, Conference Room 10, Bethesda, MD, 20892 
which was published in the Federal Register on February 26, 2016, 81 FR 
9867.
    The meeting notice is amended to change the meeting date to March 
29, 2016. The meeting is open to the public.

    Dated: March 2, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-05018 Filed 3-7-16; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.